Status:
UNKNOWN
Impact of a COVID-19 Related ICU Stay on Mental Health for Patients and Their Relatives
Lead Sponsor:
General Hospital Groeninge
Conditions:
Post Intensive Care Syndrome
PICS
Eligibility:
All Genders
18+ years
Brief Summary
As ICU mortality has been significantly decreased over the last two decades, the focus has been shifting from short term (such as ICU and hospital mortality) to long-term outcome. This evolution has l...
Detailed Description
Design: The Post Intensive Care Syndrome in COVID-19 survivors (PICOVIDS) study is an observational, single-center exploratory follow-up cohort study in a non-university hospital with 31 ICU beds. O...
Eligibility Criteria
Inclusion
- COVID-19 patient admitted to the ICU between 1st of March 2020 and 31st of May 2021
- Surviving ICU and index hospitalisation
- Respiratory failure due to COVID-19 with need for High Flow Oxygen Therapy (HFOT), non-invasive ventilation (NIV) or mechanical ventilation (MV)
- Family member (caregiver) of eligible COVID-19
- Written informed consent obtained from patient and family member
Exclusion
- ICU length of stay (ICU-LOS) \</= 72h
- Decease of the COVID-19 patient during 18-month follow-up period
- Respiratory failure and admission to ICU was not primary related to COVID-19
- Poor or moderate knowledge of Dutch, French or English language
- Mentally not able to complete questionnaires or to give informed consent, due to a neurocognitive deficit
Key Trial Info
Start Date :
March 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 31 2023
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT05348720
Start Date
March 1 2020
End Date
March 31 2023
Last Update
April 27 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
AZ Groeninge Kortrijk
Kortrijk, Belgium, 8500